Table 3.
Patients’ echocardiographic parameters in both groups
| EPO group | Control group | P value | |
|---|---|---|---|
| WMSI before CABG | 1.11±0.12 | 1.07±0.10 | 0.15 |
| WMSI 4 days after CABG | 1.08±0.09 | 1.07±0.10 | 0.83 |
| WMSI 30 days after CABG | 1.10±0.13 | 1.10±0.16 | 0.902 |
| LVEDD before CABG | 5.09± 0.70 | 4.68±0.94 | 0.314 |
| LVEDD 4 days after CABG | 4.86±0.74 | 4.73±0.59 | 0.436 |
| LVEDD 30 days after CABG | 4.95±0.68 | 4.79±0.61 | 0.434 |
| LVESD before CABG | 3.72±0.79 | 3.63±0.84 | 0.825 |
| LVESD 4 days after CABG | 3.53±0.75 | 3.67±0.54 | 0.230 |
| LVESD 30 days after CABG | 3.55±0.71 | 3.77±0.77 | 0.876 |
EPO: Erythropoietin; LVEDD: Left ventricular end-diastolic diameter; LVESD: Left ventricular end-systolic diameter